K233751 is an FDA 510(k) clearance for the Milieve (YPS-301BD). This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).
Submitted by Soterix Medical, Inc. (Woodbridge, US). The FDA issued a Cleared decision on June 3, 2024, 194 days after receiving the submission on November 22, 2023.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..